Posts

South Korea’s Move to Cover a $70,000-Plus Rare Epilepsy Drug Offers a Window Into the Global Fight Over Access to Lifesaving Medicines

0

A New Signal of Hope for Krabbe Disease Emerges From South Korea’s Labs

0

South Korea’s Push to Broaden Coverage for an SMA Drug Could Become a Test Case for Rare Disease Care

0